Compare · GEHC vs NNOX
GEHC vs NNOX
Side-by-side comparison of GE HealthCare Technologies Inc. (GEHC) and NANO-X IMAGING LTD (NNOX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GEHC and NNOX operate in Medical Electronics (Health Care), so they compete in similar markets.
- GEHC is the larger of the two at $28.76B, about 240.3x NNOX ($119.7M).
- Over the past year, GEHC is down 11.2% and NNOX is down 66.1% - GEHC leads by 54.9 points.
- GEHC has been more active in the news (4 items in the past 4 weeks vs 3 for NNOX).
- GEHC has more recent analyst coverage (25 ratings vs 3 for NNOX).
- Company
- GE HealthCare Technologies Inc.
- NANO-X IMAGING LTD
- Price
- $63.20-2.36%
- $1.72-4.97%
- Market cap
- $28.76B
- $119.7M
- 1M return
- +4.03%
- +0.00%
- 1Y return
- -11.15%
- -66.07%
- Industry
- Medical Electronics
- Medical Electronics
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- News (4w)
- 4
- 3
- Recent ratings
- 25
- 3
NANO-X IMAGING LTD
Nano-X Imaging Ltd., a development-stage company, develops, produces, and commercializes digital X-ray source technology for the medical imaging industry worldwide. Its X-ray source is based on a novel digital MEMs semiconductor cathode. The company also develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Neve Ilan, Israel.
Latest GEHC
- GE HealthCare advancing enterprise imaging with cloud-enabled solutions
- GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities
- SEC Form SD filed by GE HealthCare Technologies Inc.
- Director Lobo Kevin bought $641,800 worth of shares (10,000 units at $64.18), increasing direct ownership by 229% to 14,363 units (SEC Form 4)
- GE HealthCare upgraded by UBS with a new price target
- CEO, AIS Rackliffe Philip was granted 16,458 shares, increasing direct ownership by 62% to 43,187 units (SEC Form 4)
- CEO, Patient Care Solutions Bankes Jeannette covered exercise/tax liability with 5,535 shares, decreasing direct ownership by 13% to 38,357 units (SEC Form 4) (tax withholding)
- Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts
- Amendment: SEC Form SCHEDULE 13G/A filed by GE HealthCare Technologies Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by GE HealthCare Technologies Inc.
Latest NNOX
- Director Alroy Erez sold $1,119 worth of Ordinary Shares (678 units at $1.65), increasing direct ownership by 145% to 17,075 units (SEC Form 4)
- Nanox to Report First Quarter 2026 Financial Results on June 25, 2026
- Exclusive distribution agreement marks Nanox's entry into the Peruvian market
- Amendment: SEC Form SCHEDULE 13G/A filed by NANO-X IMAGING LTD
- Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities
- Nanox Announces Distribution Agreement with NuvioDx to Support Deployment of Nanox.ARC Systems
- SEC Form 20-F filed by NANO-X IMAGING LTD
- New insider Suesskind Dan S claimed ownership of 25,336 units of Ordinary shares (SEC Form 3)
- Nanox Signs Distribution Agreement with Radiology Oncology Systems to Expand Nanox.ARC Adoption in the United States
- Nanox Signs Commercial Agreement with Howard Technology Solutions to Deploy 300 Nanox.ARC Systems Across U.S. Over Three Years